Role of total artificial heart in the management of heart transplant rejection and retransplantation

Case report and review

Anantharam Kalya, Dawn Jaroszewski, Octavio Pajaro, Robert L Scott, Radha Gopalan, Diane Kasper, Francisco Arabia

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cardiac allograft rejection and failure may require mechanical circulatory support as bridge-to-retransplantation. Prognosis in this patient group is poor and implantable ventricular assist devices have had limited success due to organ failure associated with the high dose immunosuppression required to treat ongoing rejection. We present a case from our institution and the world-wide experience utilizing the SynCardia CardioWest Total Artificial Heart (TAH-t; SynCardia Systems, Inc., Tucson, AZ, USA) for replacement of the failing graft, recovery of patient and end-organ failure with ultimate bridge to retransplantation. We present our experience and review of world-wide experience for use of TAH-t in this type patient.

Original languageEnglish (US)
JournalClinical Transplantation
Volume27
Issue number4
DOIs
StatePublished - Jul 2013

Fingerprint

Artificial Heart
Graft Rejection
Heart-Assist Devices
Immunosuppression
Allografts
Transplants

Keywords

  • Cardiac rejection
  • Heart transplant
  • Immunosuppression
  • Retransplantation
  • Total artificial heart

ASJC Scopus subject areas

  • Transplantation

Cite this

Role of total artificial heart in the management of heart transplant rejection and retransplantation : Case report and review. / Kalya, Anantharam; Jaroszewski, Dawn; Pajaro, Octavio; Scott, Robert L; Gopalan, Radha; Kasper, Diane; Arabia, Francisco.

In: Clinical Transplantation, Vol. 27, No. 4, 07.2013.

Research output: Contribution to journalArticle

Kalya, Anantharam ; Jaroszewski, Dawn ; Pajaro, Octavio ; Scott, Robert L ; Gopalan, Radha ; Kasper, Diane ; Arabia, Francisco. / Role of total artificial heart in the management of heart transplant rejection and retransplantation : Case report and review. In: Clinical Transplantation. 2013 ; Vol. 27, No. 4.
@article{9d8e02a250e74081aa6a8f2cd1beff48,
title = "Role of total artificial heart in the management of heart transplant rejection and retransplantation: Case report and review",
abstract = "Cardiac allograft rejection and failure may require mechanical circulatory support as bridge-to-retransplantation. Prognosis in this patient group is poor and implantable ventricular assist devices have had limited success due to organ failure associated with the high dose immunosuppression required to treat ongoing rejection. We present a case from our institution and the world-wide experience utilizing the SynCardia CardioWest Total Artificial Heart (TAH-t; SynCardia Systems, Inc., Tucson, AZ, USA) for replacement of the failing graft, recovery of patient and end-organ failure with ultimate bridge to retransplantation. We present our experience and review of world-wide experience for use of TAH-t in this type patient.",
keywords = "Cardiac rejection, Heart transplant, Immunosuppression, Retransplantation, Total artificial heart",
author = "Anantharam Kalya and Dawn Jaroszewski and Octavio Pajaro and Scott, {Robert L} and Radha Gopalan and Diane Kasper and Francisco Arabia",
year = "2013",
month = "7",
doi = "10.1111/ctr.12146",
language = "English (US)",
volume = "27",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Role of total artificial heart in the management of heart transplant rejection and retransplantation

T2 - Case report and review

AU - Kalya, Anantharam

AU - Jaroszewski, Dawn

AU - Pajaro, Octavio

AU - Scott, Robert L

AU - Gopalan, Radha

AU - Kasper, Diane

AU - Arabia, Francisco

PY - 2013/7

Y1 - 2013/7

N2 - Cardiac allograft rejection and failure may require mechanical circulatory support as bridge-to-retransplantation. Prognosis in this patient group is poor and implantable ventricular assist devices have had limited success due to organ failure associated with the high dose immunosuppression required to treat ongoing rejection. We present a case from our institution and the world-wide experience utilizing the SynCardia CardioWest Total Artificial Heart (TAH-t; SynCardia Systems, Inc., Tucson, AZ, USA) for replacement of the failing graft, recovery of patient and end-organ failure with ultimate bridge to retransplantation. We present our experience and review of world-wide experience for use of TAH-t in this type patient.

AB - Cardiac allograft rejection and failure may require mechanical circulatory support as bridge-to-retransplantation. Prognosis in this patient group is poor and implantable ventricular assist devices have had limited success due to organ failure associated with the high dose immunosuppression required to treat ongoing rejection. We present a case from our institution and the world-wide experience utilizing the SynCardia CardioWest Total Artificial Heart (TAH-t; SynCardia Systems, Inc., Tucson, AZ, USA) for replacement of the failing graft, recovery of patient and end-organ failure with ultimate bridge to retransplantation. We present our experience and review of world-wide experience for use of TAH-t in this type patient.

KW - Cardiac rejection

KW - Heart transplant

KW - Immunosuppression

KW - Retransplantation

KW - Total artificial heart

UR - http://www.scopus.com/inward/record.url?scp=84881557371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881557371&partnerID=8YFLogxK

U2 - 10.1111/ctr.12146

DO - 10.1111/ctr.12146

M3 - Article

VL - 27

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 4

ER -